Strange Kevin T. - 01 Oct 2024 Form 3 Insider Report for Inari Medical, Inc.

Role: Chief Financial Officer
Signature: /s/ Shannon Trevino, attorney-in-fact for Kevin T Strange
Issuer symbol: N/A
Transactions as of: 01 Oct 2024
Net transactions value: $0
Form type: 3
Filing time: 03 Oct 2024, 16:42:10 UTC
Next filing: 03 Jan 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	NARI	Common Stock						47,355	01 Oct 2024	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	NARI	Stock Option							01 Oct 2024	Common Stock	11,761	$58.44	Direct	F1
holding	NARI	Stock Option							01 Oct 2024	Common Stock	5,293	$56.00	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These options were granted on February 15, 2024 under the Inari Medical, Inc. 2020 Incentive Award Plan and are scheduled to become vested and exercisable on a quarterly basis commencing April 1, 2024.
F2	These options were granted on February 18, 2023 under the Inari Medical, Inc. 2020 Incentive Award Plan and are scheduled to become vested and exercisable on a quarterly basis commencing April 1, 2023.